Governor Abbott Signed Yet Another Restrictive Texas Abortion Ban Into Law

Earlier this month a restrictive Texas abortion law went into effect that essentially bans abortions after six weeks. Now Governor Greg Abbott just signed another state abortion law—one that bans the use of medication abortion after seven weeks, Forbes reports.

The new law, SB 4, heavily restricts the use and distribution of abortion pills and will go into effect on December 2, barring any legal interference. For starters, SB 4 makes it illegal for a health care provider to prescribe abortion pills to a pregnant person after 49 days of pregnancy (seven weeks), which is less than the 70 days (10 weeks) the Food and Drug Administration (FDA) allows. 

On top of that, the new legislation also makes it illegal to provide patients with abortion pills by mail, delivery service, or courier. In order to receive a medication abortion in Texas within the legal time frame, patients must now undergo an in-person examination and extensive informed consent process—even while in the midst of the COVID-19 pandemic.

What’s commonly known as the abortion pill is actually two medications: First, there’s mifepristone (also called Mifeprex or RU-486). This medication begins the termination process. Then, a day or two later, comes misoprostol, which helps the uterus push the pregnancy out. 

These medications are used to safely end pregnancies before 10 weeks. Research suggests they’re safe to use even when prescribed via telemedicine. They do come with the risk for some side effects, such as cramps, bleeding, and nausea, and in rare cases (about 0.3%), they can lead to excessive bleeding or other issues that require hospitalization. But they’re generally considered quite safe medications.

Despite its safety profile, mifepristone is regulated by a Risk Evaluation and Mitigation Strategy (REMS) from the FDA, which prohibits pharmacies from dispensing the medication. The medication can be prescribed only by certain health care providers and can be given to patients only in clinics, hospitals, or doctor’s offices under the supervision of a health care provider. Some states also require the doctor to be physically in the room with the patient while they take mifepristone, the Guttmacher Institute explains

During the pandemic though, an FDA investigation did not find any increase in medication abortion-related complications when it decided not to enforce the requirement for an in-person visit to access the medications. So the new Texas medication abortion ban is yet another law that restricts access to safe, necessary health care. And even for those who can still access medication abortion in Texas, the legislation will add unnecessary barriers that make doing so even harder in the middle of an ongoing pandemic.

Related:

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Trifluridine/Tipiracil Combination Misses Mark in Metastatic Colon Cancer thumbnail

Trifluridine/Tipiracil Combination Misses Mark in Metastatic Colon Cancer

Pairing a novel cytotoxic agent with bevacizumab (Avastin) failed to improve progression-free survival (PFS) versus standard therapy in older patients with metastatic colorectal cancer (mCRC) ineligible for intensive therapy, a randomized trial showed. Investigator-assessed PFS was 9.4 months with trifluridine/tipiracil (Lonsurf) plus bevacizumab and 9.3 months with capecitabine plus the angiogenesis inhibitor. PFS by blinded…
Read More
COVID-19 pandemic exacerbated food insecurity, especially in families with children thumbnail

COVID-19 pandemic exacerbated food insecurity, especially in families with children

Credit: Unsplash/CC0 Public Domain Nearly 15 percent of U.S. households—and nearly 18 percent of households with children—reported food insecurity early in the COVID-19 pandemic, according to a survey conducted via social media by researchers at NYU School of Global Public Health. The findings, published in Nutrition Journal, illustrate how the pandemic has worsened food insecurity,…
Read More
Their Alzheimer's Disease Didn't Worsen. Why? thumbnail

Their Alzheimer’s Disease Didn’t Worsen. Why?

Neurology > Alzheimer's Disease — Case reports find one healthy habit in common by Judy George, Deputy Managing Editor, MedPage Today February 3, 2023 Sustained vigorous exercise might have slowed disease progression in two patients with positive Alzheimer's biomarkers and mild cognitive impairment, two case reports suggested. At age 64, patient 1 was diagnosed with
Read More
'This Is a Good News Story': What We Heard This Week thumbnail

‘This Is a Good News Story’: What We Heard This Week

Opinion > What We Heard This Week — Quotable quotes heard by MedPage Today's reporters by MedPage Today Staff May 14, 2023 "This is a good news story." -- Carol Mangione, MD, immediate past chair of the U.S. Preventive Services Task Force, on new draft guidance from the influential panel recommending biennial mammography screening starting
Read More
Treating depression with psilocybin or escitalopram found to result in different hierarchical brain reconfigurations thumbnail

Treating depression with psilocybin or escitalopram found to result in different hierarchical brain reconfigurations

A cartoon of the pipeline and sketch of the results. Credit: Deco et al. Depression is one of the most common mental disorders, affecting an estimated 300 million people worldwide. While there are currently numerous pharmacological treatments for depression, how different treatments impact the brains of the patients they are administered to is not yet
Read More
Index Of News